Presentation given by Sergio Figueiras from Ramón Domínguez Foundation in the framework of the Emergence Forum Barcelona Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation. More information at: http://www.b2match.eu/emergenceforum2014

1. InnovaSuMMa and PRIS projects: Health Innovation through
Precomercial Public Procurement (PCP)
Thursday 10th April, 2014
1. PRIS Project

2. • Management: Agreement with the Ministry of Economy and
Competitiveness
H2050 e Innova Saúde projects
Characteristics 2x45 M€
• Objectives:
• Provide the Galician public Health System with innovative
products and services
• Foster innovation in companies through Innovative Public
Procurement (IPP)
• Temporal Scope: 2012-2015
• Financing: Regional Development Funds, within the Operational
R&D&i Plan – Technological Fund 2007-2013 (80% ERDF)

3. PRIS Methodology
CPP
Pre-screening
Phase 0
32 projects
Projects with results and
potential to reach the market
•New therapies
•Diagnostic tools
•Medical software
•Mediacal devices
•Health services
With external
experts and
focused on the
market
Working with
innovative companies
with capacities and
technologies that cover
Research Groups
development needs.
Sharing Risks and
benefits
Evaluation
PHASE I
20 projects
Elaboration
Business Plan
PHASE II
10 projects
Co-
development
PPP financed
through PCP
PHASE II
4-5 projects

4. Fase 0
Fase I
PRIS Porfolio-Phase 1

5. PRIS Porfolio Phase 2 and 3

6. Type of services demanded PROJECTS € investment
CRO 4 projects 3, 8, 30 330.000,00
Medical device companies 2 projects 17, 27 300.000,00
Vaccine GMP manufacturer 1 project 28 150.000,00
Serious Games/Media Company 1 project 16 120.000,00
Preformulation and Drug development
company 1 project 6 200.000,00
Pharmaceutical company (Nephrology) 1 project 14 85.000,00
Total projected investments (just private sector) 1.185.000,00
PRIS Budget

7. 2. InnovaSuMMa Project

8. InnovaSuMMa project
8
• Continuing with previous experience in Galicia in PPI
• InnovaSumma : based on the project developed by ASEBIO and adapted SERGAS priorities
• Inspired in other European PCP projects
• Aiming the introduction of technologies
based on biomarkers for new patient
assistance protocols based on Personalized
medicine for Oncology

9. 9
Changing traditional procurement practices
Legal experts Procurement
Oncology
Doctors Galician
Oncology
Society
Industrial Association
Health Assistance Director
Technology evaluation
Project
management
MINECO
Health Innovation
Director

10. 10
Project executed in 3 stages /budget
Stage 1 (opened to 8-10 companies ): 1month-long.
scientific-technological proposals and the proposed work
plan to the selected Galician Oncology services
Stage 2 (opened to 6 companies): Six months-long.
Evaluating the most promising projects resulting from
phase 1, with real patients. Proving the selected
technologies in real clinical environments
Stage 3 (opened to 4 company): Six months-long. . Full
deployment of the best technologies to evaluate the
potential of biomarkers and change current clinical
protocols in the area of oncology.

11. Maximum budget per
company
Maximum number
of companies
PHASE 1
6.000,00 € 8
PHASE 2
70.000,00 € 6
PHASE 3
40.000,00 € 4
TOTAL BUDGET 628.000,00€
InnovaSuMMa Budget

12. Thank you!
Sergio Figueiras
innovacion@sergas.es